EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Antimicrobial and diagnostic stewardship: opportunities for return on investment

Tracy Zembles iD, Blake Buchan iD, Katie Ray iD, Michelle Mitchell, Kelly Graff

Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · 6 (1)

DOI: 10.1017/ash.2026.10415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 01.06.2026. Verfasst von Tracy Zembles und 4 weiteren Autor:innen. Beteiligte Einrichtung: Children's Wisconsin, Milwaukee, WI, USA. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Implementation of antimicrobial and diagnostic stewardship interventions can offer substantial return on investment while enhancing patient safety and healthcare quality. Clinical benefits include a decrease in antimicrobial resistance, shorter hospital stays, fewer adverse events from unnecessary antibiotic use, and optimized treatment protocols. We aimed to estimate the annual cost savings resulting from various interventions implemented by our Antimicrobial Stewardship Program at a single free-standing children’s hospital.

Design

Cost analysis.

Setting

Free-standing children’s hospital. Patients: Hospitalized patients.

Methods

We reviewed annual cost savings related to various targeted antimicrobial and diagnostic stewardship initiatives, including drug cost savings from guidelines and protocols, prevention of antimicrobial resistance, diagnostic stewardship interventions, penicillin allergy de-labeling, and sustainability efforts. Institution-level cost data were evaluated when feasible. Otherwise, cost estimates were extrapolated from the literature.

Results

The Antimicrobial Stewardship Program saved an estimated $4,972,805 annually. This was a result of $1,155,405 in direct drug cost savings, $2,953,216 in savings related to a decrease in multi-drug resistant organisms, $75,000 in savings from penicillin allergy de-labeling, $689,184 in savings related to diagnostic stewardship interventions, and $100,000 in savings from sustainability efforts.

Conclusions

Antimicrobial Stewardship Programs can be associated with significant cost savings, justifying the investment. Collaboration across departments, particularly with microbiology, pharmacy, infection prevention, and service providers is central to the ongoing success of stewardship efforts, underscoring the multidisciplinary strength and efficiency of the approach.

Autor:innen und Institutionen

  • Children's Wisconsin, Milwaukee, WI, USA.
  • Medical College of Wisconsin, Milwaukee, WI, USA.

ORCID-Profile: Tracy Zembles, Blake Buchan, Katie Ray

Zitieren

APA

Zembles, T., Buchan, B., Ray, K., Mitchell, M., & Graff, K. (2026). Antimicrobial and diagnostic stewardship: opportunities for return on investment. Antimicrobial Stewardship & Healthcare Epidemiology, 6(1). https://doi.org/10.1017/ash.2026.10415

Vancouver

Zembles T, Buchan B, Ray K, Mitchell M, Graff K. Antimicrobial and diagnostic stewardship: opportunities for return on investment. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(1). doi:10.1017/ash.2026.10415

BibTeX
@article{Zembles2026,
  author = {Zembles, Tracy and Buchan, Blake and Ray, Katie and Mitchell, Michelle and Graff, Kelly},
  title = {Antimicrobial and diagnostic stewardship: opportunities for return on investment},
  journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
  year = {2026},
  volume = {6},
  number = {1},
  doi = {10.1017/ash.2026.10415}
}
Kostenlos starten →